A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer
NCT05414630
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer Stage III
Interventions
DRUG:
Envafolimab
Sponsor
Anhui Provincial Cancer Hospital